MoneyWorks4Me

Tatva Chintan Pharma - Quaterly Results

18 Jul 2026 Evaluate
A decent increase of about 34.37% in the sales to Rs. 1467.02 millions was observed for the quarter ended June 2026. The sales figure stood at Rs. 1091.80 millions during the year-ago period.The Total revenue for the quarter ended June 2026 of  Rs. 104.46  millions  grew by 103.51% from Rs. 51.33 millions.Operating profit surged to 280.58 millions from the corresponding previous quarter of 164.36 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 1467.02 1091.80 34.37 1467.02 1091.80 34.37 4962.96 3664.15 35.45
Other Income 40.33 13.69 194.59 40.33 13.69 194.59 35.28 35.61 -0.93
PBIDT 280.58 164.36 70.71 280.58 164.36 70.71 928.58 294.05 215.79
Interest 20.81 4.13 403.87 20.81 4.13 403.87 28.51 12.90 121.01
PBDT 246.59 160.23 53.90 246.59 160.23 53.90 900.07 281.15 220.14
Depreciation 105.65 89.69 17.79 105.65 89.69 17.79 368.42 276.54 33.22
PBT 140.94 70.54 99.80 140.94 70.54 99.80 531.65 4.61 11432.54
TAX 36.48 19.21 89.90 36.48 19.21 89.90 140.83 1.34 10409.70
Deferred Tax 36.48 7.09 414.53 36.48 7.09 414.53 40.16 1.32 2942.42
PAT 104.46 51.33 103.51 104.46 51.33 103.51 390.82 3.27 11851.68
Equity 233.92 233.92 0.00 233.92 233.92 0.00 233.92 233.92 0.00
PBIDTM(%) 19.13 15.05 27.05 19.13 15.05 27.05 18.71 8.03 133.15
Peers
Company Name CMP
Godrej Industries 1073.40
SRF 2490.00
BASF India 3493.40
Pidilite Inds. 1499.05
Tata Chemicals 641.65
View more..